Sign in

CIK 0001642380

  • Non-accelerated filer
  • Smaller reporting company

Insight Molecular Diagnostics Inc.

Sign in to watch
Ticker
IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
271041563
Phone
+1 949-409-7600
Business address
2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
Former names
OncoCyte Corp, Oncocyte Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 23 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-03-14 Levine Mitchell S Chief Financial Officer Option exercise +20,000 33,495
2020-03-14 Levine Mitchell S Chief Financial Officer Shares withheld for taxes −6,916 26,579
2020-03-14 Levine Mitchell S Chief Financial Officer Option exercise · Restricted Stock Units −20,000 0
2020-02-10 Levine Mitchell S Chief Financial Officer Grant or award · Option to purchase common stock +204,000 204,000
2020-02-10 KALAJIAN TONY T SVP, Chief Accounting Officer Grant or award · Option to purchase common stock +204,000 204,000
2020-02-10 Parker Albert P Chief Operating Officer Grant or award · Option to purchase common stock +204,000 204,000
2020-02-10 Sundar Padma SVP, Marketing & Market Access Grant or award · Option to purchase common stock +255,000 255,000
2020-01-02 Lineage Cell Therapeutics, Inc. Previous 10% Owner Sale −2,383,090 $2.16 $5.1M 6,041,154
2020-01-02 BROADWOOD PARTNERS, L.P. 10% owner Purchase +768,376 $2.16 $1.7M 13,043,114
2020-01-02 BROADWOOD PARTNERS, L.P. 10% owner Purchase +0 13,043,114
2020-01-02 BROADWOOD PARTNERS, L.P. 10% owner Purchase +623,090 $2.16 $1.3M 13,666,204
2020-01-02 BROADWOOD PARTNERS, L.P. 10% owner Purchase +0 13,666,204
2019-11-13 BROADWOOD PARTNERS, L.P. 10% owner Purchase +1,176,471 $1.70 $2.0M 12,274,738
2019-11-13 BROADWOOD PARTNERS, L.P. 10% owner Purchase +0 12,274,738
2019-09-17 Arno Andrew Director Purchase +50,000 $2.16 $108K 102,447
2019-09-13 KALAJIAN TONY T SVP-Chief Accounting Officer Purchase +10,000 $1.98 $20K 10,000
2019-09-12 Levine Mitchell S CFO Purchase +10,000 $2.01 $20K 13,495
2019-09-12 Levine Mitchell S Chief Financial Officer Purchase +10,000 $2.01 $20K 10,000
2019-09-11 Lineage Cell Therapeutics, Inc. 10% owner Sale −4,000,000 $1.66 $6.6M 8,424,244
2019-09-11 BROADWOOD PARTNERS, L.P. 10% owner Purchase +2,000,000 $1.66 $3.3M 11,098,267

Page 17 of 20 · 383 trades